Ocular Therapeutix, Inc. (OCUL)
10.78
-0.30
(-2.71%)
USD |
NASDAQ |
Aug 24, 16:00
10.78
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Shareholders Equity (Quarterly) : 520.04M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 520.04M |
| March 31, 2026 | 581.57M |
| December 31, 2025 | 654.31M |
| September 30, 2025 | 258.23M |
| June 30, 2025 | 305.92M |
| March 31, 2025 | 265.93M |
| December 31, 2024 | 315.34M |
| September 30, 2024 | 352.02M |
| June 30, 2024 | 377.70M |
| March 31, 2024 | 407.98M |
| December 31, 2023 | 91.13M |
| September 30, 2023 | 7.853M |
| June 30, 2023 | 3.087M |
| March 31, 2023 | 9.711M |
| December 31, 2022 | 35.38M |
| September 30, 2022 | 46.23M |
| June 30, 2022 | 65.80M |
| March 31, 2022 | 79.80M |
| December 31, 2021 | 88.00M |
| September 30, 2021 | 87.34M |
| June 30, 2021 | 80.25M |
| March 31, 2021 | 83.41M |
| December 31, 2020 | 76.10M |
| September 30, 2020 | -4.126M |
| June 30, 2020 | 5.344M |
| Date | Value |
|---|---|
| March 31, 2020 | -10.66M |
| December 31, 2019 | -3.63M |
| September 30, 2019 | 11.30M |
| June 30, 2019 | 8.258M |
| March 31, 2019 | 25.65M |
| December 31, 2018 | 35.88M |
| September 30, 2018 | 45.52M |
| June 30, 2018 | 45.73M |
| March 31, 2018 | 49.18M |
| December 31, 2017 | 26.15M |
| September 30, 2017 | 35.92M |
| June 30, 2017 | 48.02M |
| March 31, 2017 | 63.90M |
| December 31, 2016 | 52.01M |
| September 30, 2016 | 62.29M |
| June 30, 2016 | 70.45M |
| March 31, 2016 | 80.17M |
| December 31, 2015 | 89.59M |
| September 30, 2015 | 98.81M |
| June 30, 2015 | 109.11M |
| March 31, 2015 | 52.07M |
| December 31, 2014 | 58.70M |
| September 30, 2014 | 65.60M |
| June 30, 2014 | 4.92M |
| March 31, 2014 | 10.75M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint, Inc. | 166.41M |
| LENZ Therapeutics, Inc. | 219.26M |
| Merck & Co., Inc. | 41.93B |
| Theravance Biopharma, Inc. | 289.70M |
| ANI Pharmaceuticals, Inc. | 597.21M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 671.32M |
| Total Liabilities (Quarterly) | 151.28M |
| Debt to Equity Ratio | 0.1526 |
| Current Ratio | 13.10 |
| Net Debt Paydown Yield | -0.03% |